GlassScriptPhysician profile
Nancy A Feltner
NPI 1437548070
$2,977.26
in general payments reported to CMS, 2019-2025
17 companies · $873 in 2025
The $873 reported for 2025 was more than what 78% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $463 · 2022: $573 · 2023: $421 · 2024: $647 · 2025: $873.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,941.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,941.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $868.50 | 2021-2025 | |
| Supernus Pharmaceuticals, INC. | $632.23 | 2021-2025 | Qelbree, Qelbree |
| Otsuka America Pharmaceutical, INC. | $456.00 | 2021-2025 | Abilify Maintena, Abilify Asimtufii, Rexulti |
| Lundbeck LLC | $289.17 | 2021-2025 | Rexulti |
| Takeda Pharmaceuticals U.S.A., INC. | $167.88 | 2021-2024 | Trintellix |
| Jazz Pharmaceuticals INC. | $135.96 | 2022-2023 | |
| Exact Sciences Corporation | $79.84 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| E.R. Squibb & Sons, L.L.C. | $68.78 | 2025 | Cobenfy |
| Bayer Healthcare Pharmaceuticals INC. | $57.62 | 2023 | |
| Ironshore Pharmaceuticals INC. | $53.73 | 2023 | Jornay Pm |
| Neurocrine Biosciences, INC. | $44.27 | 2024 | Ingrezza |
| Teva Pharmaceuticals USA, INC. | $30.36 | 2025 | Uzedy |
| Sunovion Pharmaceuticals INC. | $23.21 | 2022 | |
| Bausch Health US, LLC | $19.13 | 2024 | Aplenzin |
| Gilead Sciences, INC. | $17.94 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $16.32 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.32 | 2025 | Xifaxan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Feltner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.